Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
A Sustainable and Efficient Synthesis of Benzyl Phosphonates Using PEG/KI Catalytic System.

Frontiers in chemistry

Disale S, Kale S, Abraham G, Kahandal S, Sawarkar AN, Gawande MB.
PMID: 27579301
Front Chem. 2016 Aug 16;4:35. doi: 10.3389/fchem.2016.00035. eCollection 2016.

An efficient and expedient protocol for the synthesis of benzyl phosphonates using KI/K2CO3 as a catalytic system and PEG-400 as benign solvent has been developed. The reaction proceeds smoothly at room temperature achieving excellent selectivity and yield of the...

Euthymia in Diabetes: Clinical Evidence and Practice-Based Opinion from an International Expert Group.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Das AK, Baruah MP, Unnikrishnan AG, Dasgupta A, Shah P, Sahay R, Shukla R, Das S, Tiwaskar M, Vijayakumar G, Chawla M, Eliana F, Suastika K, Orabi A, Rahim AAA, Uloko A, Lamptey R, Ngugi N, Bahendeka S, Abdela AA, Mohammed F, Pathan MF, Rahman MH, Afsana F, Selim S, Moosa M, Murad M, Shreshtha PK, Shreshtha D, Giri M, Hussain W, Al-Ani A, Ramaiya K, Singh S, Raza SA, Aye TT, Garusinghe C, Muthukuda D, Weerakkody M, Kahandawa S, Bavuma C, Ruder S, Vanny K, Khanolkar M, Czupryniak L.
PMID: 31012081
Diabetes Ther. 2019 Jun;10(3):791-804. doi: 10.1007/s13300-019-0614-6. Epub 2019 Apr 22.

AIM: To develop an evidence-based expert group opinion on various types of euthymia associated with diabetes mellitus (DM) and its management.BACKGROUND: Diabetes mellitus is a metabolic syndrome characterized by diverse biomedical and psychosocial features. Emotional health disturbances may lead...

Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Das AK, Baruah MP, Unnikrishnan AG, Dasgupta A, Shah P, Sahay R, Shukla R, Das S, Tiwaskar M, Vijayakumar G, Chawla M, Eliana F, Suastika K, Orabi A, Rahim AAA, Uloko A, Bahendeka S, Abdela AA, Mohammed F, Pathan F, Rahman MH, Afsana F, Selim S, Moosa M, Murad M, Shreshtha PK, Shreshtha D, Giri M, Hussain W, Al-Ani A, Ramaiya K, Singh S, Raza SA, Aye TT, Garusinghe C, Muthukuda D, Weerakkody M, Kahandawa S, Bavuma C, Ruder S, Vanny K, Khanolkar M, Czupryniak L.
PMID: 31267358
Diabetes Ther. 2019 Oct;10(5):1577-1593. doi: 10.1007/s13300-019-0651-1. Epub 2019 Jul 02.

AIM: The primary objective of this document is to develop practice-based expert group opinion on certain important but less discussed endocrine and metabolic effects of modern sulfonylureas (SUs) and their usage in the management of diabetes mellitus (DM).BACKGROUND: Modern...

Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Das AK, Bajaj S, Priya G, Ghosh S, Mehrotra RN, Das S, Shah P, Deshmukh V, Sanyal D, Chandrasekaran S, Khandelwal D, Joshi A, Nair T, Eliana F, Permana H, Fariduddin MD, Shrestha PK, Shrestha D, Kahandawa S, Sumanathilaka M, Shaheed A, Rahim AAA, Orabi A, Al-Ani A, Hussein W, Kumar D, Shaikh K.
PMID: 31916214
Diabetes Ther. 2020 Feb;11(2):411-422. doi: 10.1007/s13300-019-00753-5. Epub 2020 Jan 08.

AIM: The primary objective of this review is to develop a practice-based expert group opinion on the role of precision medicine with a specific focus on sulfonylureas (SUs) in diabetes management.BACKGROUND: The clinical etiology, presentation and complications of diabetes...

Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel.

Journal of family medicine and primary care

Kalra S, Das AK, Priya G, Ghosh S, Mehrotra RN, Das S, Shah P, Bajaj S, Deshmukh V, Sanyal D, Chandrasekaran S, Khandelwal D, Joshi A, Nair T, Eliana F, Permana H, Fariduddin MD, Shrestha PK, Shrestha D, Kahandawa S, Sumanathilaka M, Shaheed A, Rahim AA, Orabi A, Al-Ani A, Hussein W, Kumar D, Shaikh K.
PMID: 33532378
J Family Med Prim Care. 2020 Nov 30;9(11):5450-5457. doi: 10.4103/jfmpc.jfmpc_843_20. eCollection 2020 Nov.

Type 2 diabetes mellitus (T2DM) is a progressive disease with multifactorial etiology. The first-line therapy includes monotherapy (with metformin), which often fails to provide effective glycemic control, necessitating the addition of add-on therapy. In this regard, multiple single-dose agents...

Showing 1 to 5 of 5 entries